In a follow up study we tested a higher concentration () of PR022 HOCl gel in comparison to the Janus kinase inhibitor tofacitinib, both of which are currently in clinical phase studies for treatment of human atopic dermatitis. | Comparison of topical tofacitinib and hypochlorous acid in a murine atopic dermatitis model